| Sieber, Stephan (TU Munich 202007 Professor) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Sieberer, Thomas (Biocrates 2003) |
n. a. |
Biocrates (Group) |
Austria |
| Siebert, Alexander (Trophic Communications 202307) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Siegel, Oliver (Affiris 201506– CEO joined 201409 as COO before Rothschild in London + HSBC plc) |
Chief Executive Officer (CEO) |
Affiris AG |
Austria |
| Sieker, Olaf (MeVis Medical 2007Q3–200812 CFO left 1/09) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
| Sieler, Miguel (Neovacs 201310 CEO before Bayer France CEO at Bayer since 1975) |
Chief Executive Officer (CEO) |
Neovacs (Group) |
France |
| Sieper, Albrecht (Elementar 201701 Managing Director of Elementar Analystensysteme GmbH) |
Managing Director |
Elementar (Group) |
Germany |
| Sieper, Hans-Peter (Elementar 201701 Managing Director of Elementar Analystensysteme GmbH) |
Managing Director |
Elementar (Group) |
Germany |
| Siesel, Peter (Tecan 201106 VP Sales + Marketing Tecan US) |
Sales Manager / Marketing Manager |
Tecan (Group) |
United States (USA) |
| Sietzema, Sietze (Lactotronic 201807 Founder) |
Company Founder |
Bruker (Group) |
Netherlands |
| Sievers, Stephan (NuVasive 200909 Managing Director NuVasive Europe GmbH) |
Managing Director |
NuVasive (Group) |
Germany |
| Sievert, Dominik (Inveox GmbH 201702– Managing Director + Co-Founder) |
Managing Director |
Inveox (Group) |
Germany |
| Sievert, Jörg (SAP 201209 Managing Director of SAP Ventures) |
Managing Director |
SAP (Group) |
Germany |
| Sievert, Maria (formerly Driesel) (Inveox GmbH 201702– Managing Director + Co-Founder) |
Managing Director |
Inveox (Group) |
Germany |
| Siffert, João (Abeona 201811– Interim CEO before Head RnD + CMO before AveXis + Ceregene + Avanir + Avera + Nestlé) |
Chief Executive Officer (CEO) |
Abeona Therapeutics Inc. (Nasdaq: ABEO) |
United States (USA) |
| Sigrist, Vincent (Qiagen 200408 General Manager Qiagen Switzerland) |
n. a. |
Qiagen (Group) |
Switzerland |
| Sikka, Vishal (SAP 201206 Executive Board Member) |
Board member, executive |
SAP (Group) |
Germany |
| Sikri, Vishal (NeoGenomics 202205– CCO of Inivata before Biocartis + Sysmex Inostics + Sysmex + Abbott) |
General Manager (management) |
NeoGenomics (Group) |
United Kingdom (GB) |
| Silcock, Paul (Thermo Fisher 201106 GC-MS/MS Product Manager) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Silva, Jeffrey C. (Adeptrix 202101 CTO) |
Chief Technology/Technical Officer (CTO) |
Adeptrix Corporation |
United States (USA) |
| Silva, Pedro Freire (DeepSpin 202006 Managing Director (CTO) + Co-Founder) |
Managing Director |
DeepSpin GmbH |
Germany |
| Silverberg Michal (Novartis 201809 Managing Director of Novartis Venture Fund) |
Managing Director |
Novartis (Group) |
Switzerland |
| Silverman, Bob (Gilde Healthcare 201305– Operational Partner before mtm laboratories 200807– CEO joined mtm 2005) |
Investment Manager |
Gilde Investment (Group) |
Netherlands |
| Silvernail, Andy (Idex Corp 201712 CEO) |
Chief Executive Officer (CEO) |
IDEX Corporation (Group) |
United States (USA) |
| Silverstein, Jordan (Immatics 202003 Head of Corporate Strategy before InflaRx + Advanced Accelerator Applications) |
Business Development Manager / Strategy Manager |
Immatics (Group) |
Netherlands |
| Silvola, Tero (BC Platforms 201705 CEO) |
Chief Executive Officer (CEO) |
BC Platforms (BCP) (Group) |
Switzerland |
| Simhon, Shalom (Israel (govt) 201103 Minister of Industry, Trade and Labour) |
Minister |
Israel (govt) |
Israel |
| Simmat, Olaf (QInstruments 202110 CEO + Co-Founder) |
Managing Director |
|
|
| Simmons, David (Storm Therapeutics 201702 Head of Biology before Cellzome CSO + Celltech + Wyeth Research Boston) |
Research & Development Manager |
Storm Therapeutics Ltd. |
United Kingdom (GB) |
| Simmons, Jeffrey N. (Elanco 200705 Exec Director Global Strategy, RnD + Operations) |
n. a. |
Elanco (Group) |
United States (USA) |
| Simon, Arno (Beyontics GmbH 201108 Managing Director) |
Managing Director |
Beyontics GmbH |
Germany |
| Simon, Melissa (Strüngmann Group 202105 at Athos KG) |
Investment Manager |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Simon, Susanne (Bayern (govt) 201504 Manager Public Relations at IZB) |
Public Relations Manager / Investor Relations Manager |
Bavaria (govt region) |
Germany |
| Simon, Ulrich (Carl Zeiss 200412 Head Microscopy business group) |
General Manager (management) |
Carl Zeiss (Group) |
Germany |
| Simonsen, Kim (Anergis 201506– Chief Development Officer before Ablynx + ALK-Abello + Medicon A/S + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Anergis S.A. |
Switzerland |
| Simpson, David (Dave) (Glythera 201801 CEO before COO) |
Chief Executive Officer (CEO) |
Iksuda Therapeutics Ltd. |
United Kingdom (GB) |
| Simsa, Robin (Revo Foods 202209 Managing Director) |
Managing Director |
Revo Foods GmbH |
Austria |
| Sinclair, Mike (Halsin Partners 201110 Partner + Co-founder before Burns McClellan) |
Public Relations Manager / Investor Relations Manager |
Halsin Partners Ltd. |
United Kingdom (GB) |
| Sinemus, Kristina (Genius GmbH 201212 Managing Director + Prof at Quadriga Hochschule Berlin) |
Managing Director |
ECCO (Group) |
Germany |
| Singer, Wolf (Max Planck Institute for Brain Research 200808 Director) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Singh, Ajit (BioImagene 201008 CEO) |
Chief Executive Officer (CEO) |
BioImagene (Group) |
United States (USA) |
| Singh, Harpreet (Immatics 201907– CEO before CSO + CEO of Immatics US + Co-Founder) |
Chief Executive Officer (CEO) |
Immatics (Group) |
Germany |
| Singh, Mahavir (Lionex 200808 Managing Director) |
Managing Director |
Lionex Diagnostics & Therapeutics GmbH |
Germany |
| Singhofer-Wowra, Monika (Glycotype 200809 Managing Director of Glycotope Biotechnology GmbH before Orpegen GmbH) |
Managing Director |
Celonic (Group) |
Germany |
| Singlehurst, Peter (Baillie Gifford 201511 Investment Analyst) |
Analyst (Financial / Industry) |
Baillie Gifford |
United Kingdom (GB) |
| Sinha, Vikas (ElevateBio 201905 CFO formerly Alexion + Bayer Pharmaceuticals Corp) |
Chief Financial Officer (CFO) |
ElevateBio (Group) |
United States (USA) |
| Sinz, Andrea (Univ Halle 2010 Prof Institute for Pharmacy + 201702 President of DGMS) |
Professor |
University of Halle (Martin-Luther Universität Halle-Wittenberg) |
Germany |
| Siodla, Vilma (Co.don 201202 COO) |
Chief Operating Officer (COO) |
ReLive (Group) |
Germany |
| Sirinakis, Kyp (Epidarex Capital 201701 Managing Partner before Rock Spring Ventures) |
Managing Partner (investment firm) |
Epidarex Capital (Group) |
United Kingdom (GB) |
| Sirk, Kimberley (Cytel 202309 Senior Director Content + Communications) |
Public Relations Manager / Investor Relations Manager |
Cytel (Group) |
United States (USA) |
| Sitkovsky, Michail (RedoxTherapies Founder) |
Company Founder |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Sjöström, Michael |
n. a. |
Pictet (Group) |
Switzerland |
| Skentelbery, Claire (EuropaBio 202011– Director General before nia + CEBR + EBF) |
Cluster Manager |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Skerra, Arne (XL-protein GmbH 201104 Managing Director) |
Managing Director |
XL-protein GmbH (XLp) |
Germany |
| Skinner, Henry (Tekla Capital 202005 before Novartis 201201 Managing Director of Novartis Venture Fund) |
Managing Director |
Tekla Capital Management LLC |
United States (USA) |
| Skorka, Kaja (MC Services 201903 Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Skullerud, Erik (Nordic Nanovector 202109– CEO before Element Consulting GmbH + Amgen + Bayer) |
Chief Executive Officer (CEO) |
Nordic Nanovector (Group) |
Norway |
| Slack, David (Novimmune 201402 Head Corporate + Business Development LEFT 9/14) |
Business Development Manager / Strategy Manager |
Novimmune S.A. |
Switzerland |
| Slack, Mark (Evotec 200905 Senior Scientist) |
Researcher (industry) |
Evotec (Group) |
Germany |
| Slade, Andrew (Menarini 201303 President of Menarini Biologics) |
President/Director/Head Business Group/Unit/Division |
Menarini (Group) |
Italy |
| Sladek, Barbara (Biome Diagnostics 202301 Managing Director + Co-Founder) |
Managing Director |
Biome Diagnostics GmbH |
Austria |
| Slaoui, Moncef (GSK –201707 Chairman Vaccines TO RETIRE 6/17) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
| Slawinski, Kristen (Chempetitive 201506) |
Public Relations Manager / Investor Relations Manager |
CG Life (Group) |
United States (USA) |
| Sleight, Andrew (AB2 Bio 201602 CEO before 21y at Roche) |
Chief Executive Officer (CEO) |
AB2 Bio S.A. |
Switzerland |
| Slikker, William, Jr., PhD (FDA 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
| Slingsby, Jason (LifeArc 202305– CBO before Oxford Biomedica + Miti Biosystems + ProtAffin) |
Business Development Manager / Strategy Manager |
LifeArc (GB) |
United Kingdom (GB) |
| Slobod, Karen (CureVac 201509– Managing Director of new US subsidiary before at Novartis Vaccines) |
Managing Director |
CureVac (Group) |
United States (USA) |
| Slootweg, Sander (Forbion Capital Partners 20111 Managing Partner before ABN AMRO Capital) |
Managing Partner (investment firm) |
Forbion (Group) |
Netherlands |
| Slot, Reinout (CMS Derks Star Busman 201511) |
Attorney / Lawyer |
CMS (Group) |
Netherlands |
| Smedegaard, Peter (Syddansk Innovation 201809 investment + Portfolio Manager) |
Investment Manager |
Syddansk Innovation (SDI) |
Denmark |
| Smedley, Mark (Life Technologies 201008 Head Asia Pacific region before Invitrogen before Novartis) |
Regional manager |
Thermo Fisher (Group) |
United States (USA) |
| Smets, Martha (Life Science Venture Fund 202302 Investment Director + Blue Ribbon Partners 202302 Venture Partner) |
Investment Manager |
Life Science Valley (Sartorius / Niedersachsen/ Univ Göttingen) (Group) |
Germany |
| Smettan, Gerhard (AZ Biopharm 201105 Business Development) |
Business Development Manager / Strategy Manager |
Analytisches Zentrum Biopharm GmbH Berlin (AZ Biopharm) |
Germany |
| Smit, Ralf (Eleva 202101– CBO before advisor to Eleva + at BioStrat + Roche) |
Chief Business Officer (CBO) |
Eleva GmbH |
Germany |
| Smith, Adrian (Sysmex 202204– CEO of Oxford Gene Technology before Hologic UK/IE + Qiagen + Roche) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
United Kingdom (GB) |
| Smith, Andrew (GeneBio 200503 Marketing Manager) |
Sales Manager / Marketing Manager |
GeneBio (Group) |
Switzerland |
| Smith, Andrew (Santhera 202004– CFO before Allecra Therapeutics + Sucampo Pharmaceuticals) |
Chief Financial Officer (CFO) |
Santhera (Group) |
Switzerland |
| Smith, Angus (Affimed 202007– CFO based in US before Rockwell Medical + Pernix Therapeutics + Cantor Fitzgerald) |
Chief Financial Officer (CFO) |
Affimed (Group) |
Germany |
| Smith, Brendan (CRISPR Therapeutics 202110–202303 CFO before Translate Bio + Boston Consulting + Pfizer LEFT 3/23) |
Chief Financial Officer (CFO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Smith, David (Lonza 201502 Head of Cell Therapy, Lonza Custom Manufacturing) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
United States (USA) |
| Smith, David R. (Galapagos 201308– CFO/CEO services division before Cambridge Univ Hospitals + Galapagos + AstraZeneca) |
Chief Financial Officer (CFO) |
Galapagos (Group) |
Belgium |
| Smith, Erin (PAN Communications 201908) |
Public Relations Manager / Investor Relations Manager |
PAN Communications (Boston) |
United States (USA) |
| Smith, John (Peak Scientific 201304 Head of Gas) |
n. a. |
Peak Scientific (Group) |
United Kingdom (GB) |
| Smith, Jonathan (PaxVax 201609 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
PaxVax (Group) |
United States (USA) |
| Smith, Marcus (Recipharm 202202 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Recipharm (Group) |
Sweden |
| Smith, Paul (Axela 201605 President) |
President/Director/Head Business Group/Unit/Division |
Axela Inc. |
Canada |
| Smith, Richard E. T. (StrideBio 201704 Director Operations) |
Chief Operating Officer (COO) |
StrideBio Inc. |
United States (USA) |
| Smith, Sean R. (ImmunOs Therapeutics 201912 CEO) |
Chief Executive Officer (CEO) |
Immunostep (ES) |
Spain (España) |
| Smith, Trevor (Takeda –201503 Takeda Pharmaceuticals International GmbH LEFT 3/15 |
n. a. |
Takeda (Group) |
Switzerland |
| Smits, Philip (Schering AG 200510) |
n. a. |
Bayer (Group) |
Germany |
| Snyder, Scott (Evotec 201304 EVP Compound Management) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Soenksen, Dirk G. (Aperio 201105 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Sohier, Daniele (Bruker 201802 Business Development Manager for Industrial Microbiology at Bruker Daltonics) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
United States (USA) |
| Sohler, Matthias (Yabeo Capital GmbH 202002 Managing Director + Founder) |
Managing Director |
Yabeo Capital GmbH |
Germany |
| Soignet, Steven L. (Arcus Ventures 2007– General Partner + Co-founder) |
General Partner (venture partner) |
Arcus Ventures |
United States (USA) |
| Sojeva, Brittney (MC Services 202101) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Sola, Josep (Aktiia 201805– CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Aktiia S.A. |
Switzerland |
| Soldan, Michael (Polpharma Biologics 202208 CEO) |
Chief Executive Officer (CEO) |
Polpharma (Group) |
Poland |
| Soldo, Josh (Anteo Technologies 201507 VP Sientific Affairs) |
Research & Development Manager |
Anteo Technologies (AU) |
Australia |
| Solibieda, Markus (BASF 201902 Managing Director at BASF Venture Capital) |
Managing Director |
BASF (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 71 72 73 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
